A neurostimulation device developed for weight management. The device received FDA approval and represents Neurovalens' non-invasive neuromodulation technology applied to weight management treatment.
Manufactured by
Neurovalens
United Kingdom
Neurovalens is a UK-based medical technology company developing head-worn, non-invasive vestibular stimulation devices for neurological and mental health conditions. The company holds FDA 510(k) clearance for the treatment of insomnia and anxiety, with its drug-free wearable technology also being app-controlled for enhanced patient compliance and personalized treatment monitoring.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Brainsecrets.co.,Ltd
South Korea · 1 relevant product
Paragon Medical Corporation
United States · 1 relevant product
Bottneuro AG
Switzerland · 2 relevant products
48 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 24 relevant matches
Brainsecrets.co.,Ltd · South Korea
Therapeutic device for modulating neural activity through electrical or magnetic stimulation for neurological disorder treatment.
Paragon Medical Corporation · United States
Neuromodulation systems engineered and manufactured with advanced design capabilities for neurological therapeutic applications.
Bottneuro AG · Switzerland
An electrical neurostimulator device designed for personalized brain health treatment. The MIAMIND is being evaluated in a randomized, sham-controlled clinical trial for patients with early-stage Alzheimer's disease, with support from Innosuisse funding. This innovative neurostimulation device represents precision medicine technology for neurological conditions.
21 more relevant matches available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products